Prostate Cancer, Genomics & Public Health
CDC information: Prostate cancer-risk factors, symptoms and screening
NCI information: Genetics of prostate cancer (PDQ)
Technology assessment report: Gene expression analysis for prostate cancer management, Blue Cross Blue Shield Health Technology Assessment Report, May 2014
Blue Cross Blue Shield Health Technology Assessment Report, May 2014EGAPP recommendation: Does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes? (2013)
(2013)Prospects for genetic risk screening in prostate cancer, PHG Foundation, Feb 23
PHG Foundation, Feb 23Recent papers:
NF-κB gene signature predicts prostate cancer progression.
Renjie Jin et al. Cancer Research
Renjie Jin et al. Cancer Research
Prostate Cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM, et al. Eur Urol. 2014 Jun;65(6):1069-75.
Shui IM, et al. Eur Urol. 2014 Jun;65(6):1069-75.
Genetic variants in predicting aggressive prostate cancer: “Ready for prime time?”
Adriana C. Vidal et al. European Urology: 01 June 2014
Adriana C. Vidal et al. European Urology: 01 June 2014
Influence of a genomic classifier on postoperative treatment decisions in high-risk prostate cancer patients: Results from the PRO-ACT study
Michalopoulos SN, et al. Curr Med Res Opin 2014 May
Michalopoulos SN, et al. Curr Med Res Opin 2014 May
.png)
No hay comentarios:
Publicar un comentario